EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Endometrial Neoplasms
  • Receptor, EphA2
  • Receptors, Estrogen
  • Receptors, Progesterone

abstract

  • EphA2 overexpression was associated with aggressive phenotypic features in EEC and was associated inversely with ER and PR expression. Thus, EphA2 may be an important therapeutic target, especially in patients with hormone receptor-negative endometrial carcinoma.

publication date

  • June 15, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3139331

Digital Object Identifier (DOI)

  • 10.1002/cncr.24335

PubMed ID

  • 19396818

Additional Document Info

start page

  • 2684

end page

  • 92

volume

  • 115

number

  • 12